Association Between Proportion of Nuclei With High Chromatin Entropy and Prognosis in Gynecological Cancers

Abstract Background Nuclear texture analysis measuring differences in chromatin structure has provided prognostic biomarkers in several cancers. There is a need for improved cell-by-cell chromatin analysis to detect nuclei with highly disorganized chromatin. The purpose of this study was to develop a method for detecting nuclei with high chromatin entropy and to evaluate the association between the presence of such deviating nuclei and prognosis. Methods A new texture-based biomarker that characterizes each cancer based on the proportion of high–chromatin entropy nuclei (<25% vs ≥25%) was developed on a discovery set of 175 uterine sarcomas. The prognostic impact of this biomarker was evaluated on a validation set of 179 uterine sarcomas, as well as on independent validation sets of 246 early-stage ovarian carcinomas and 791 endometrial carcinomas. More than 1 million images of nuclei stained for DNA were included in the study. All statistical tests were two-sided. Results An increased proportion of high–chromatin entropy nuclei was associated with poor clinical outcome. The biomarker predicted five-year overall survival for uterine sarcoma patients with a hazard ratio (HR) of 2.02 (95% confidence interval [CI] = 1.43 to 2.84), time to recurrence for ovarian cancer patients (HR = 2.91, 95% CI = 1.74 to 4.88), and cancer-specific survival for endometrial cancer patients (HR = 3.74, 95% CI = 2.24 to 6.24). Chromatin entropy was an independent prognostic marker in multivariable analyses with clinicopathological parameters (HR = 1.81, 95% CI = 1.21 to 2.70, for sarcoma; HR = 1.71, 95% CI = 1.01 to 2.90, for ovarian cancer; and HR = 2.03, 95% CI = 1.19 to 3.45, for endometrial cancer). Conclusions A novel method detected high–chromatin entropy nuclei, and an increased proportion of such nuclei was associated with poor prognosis. Chromatin entropy supplemented existing prognostic markers in multivariable analyses of three gynecological cancer cohorts.

[1]  C. Sessa,et al.  Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

[2]  Nicolai J. Birkbak,et al.  Tracking the Evolution of Non‐Small‐Cell Lung Cancer , 2017, The New England journal of medicine.

[3]  Fritz Albregtsen,et al.  Changes in Chromatin Structure in Curettage Specimens Identifies High-Risk Patients in Endometrial Cancer , 2016, Cancer Epidemiology, Biomarkers & Prevention.

[4]  M. Novelli,et al.  Revisiting tumour aneuploidy — the place of ploidy assessment in the molecular era , 2016, Nature Reviews Clinical Oncology.

[5]  Fritz Albregtsen,et al.  Chromatin changes predict recurrence after radical prostatectomy , 2016, British Journal of Cancer.

[6]  J. Marcickiewicz,et al.  DNA ploidy in curettage specimens identifies high-risk patients and lymph node metastasis in endometrial cancer , 2015, British Journal of Cancer.

[7]  A. Shilatifard,et al.  Chromatin signatures of cancer , 2015, Genes & development.

[8]  Fritz Albregtsen,et al.  Entropy-Based Adaptive Nuclear Texture Features are Independent Prognostic Markers in a Total Population of Uterine Sarcomas , 2014, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[9]  J. Ledermann,et al.  Optimal treatment of early-stage ovarian cancer , 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

[10]  J. Trovik,et al.  Markers for individualised therapy in endometrial carcinoma. , 2012, The Lancet. Oncology.

[11]  V. Abeler,et al.  Diagnosis and treatment of sarcoma of the uterus. A review , 2012, Acta oncologica.

[12]  Fritz Albregtsen,et al.  The Prognostic Value of Adaptive Nuclear Texture Features from Patient Gray Level Entropy Matrices in Early Stage Ovarian Cancer , 2012, Analytical cellular pathology.

[13]  F Albregtsen,et al.  Comparison of nuclear texture analysis and image cytometric DNA analysis for the assessment of dysplasia in Barrett's oesophagus , 2011, British Journal of Cancer.

[14]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[15]  S. Pecorelli.  Corrigendum to “Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium” , 2010 .

[16]  V. Abeler,et al.  The prognostic value of DNA ploidy in a total population of uterine sarcomas. , 2009, Annals of oncology : official journal of the European Society for Medical Oncology.

[17]  J. Nesland,et al.  Uterine sarcomas in Norway. A histopathological and prognostic survey of a total population from 1970 to 2000 including 419 patients , 2009, Histopathology.

[18]  R. Labianca,et al.  Endpoints in adjuvant treatment trials: a systematic review of the literature in colon cancer and proposed definitions for future trials. , 2007, Journal of the National Cancer Institute.

[19]  L. Akslen,et al.  Pathologic expression of p53 or p16 in preoperative curettage specimens identifies high-risk endometrial carcinomas. , 2006, American journal of obstetrics and gynecology.

[20]  V. Abeler,et al.  Image cytometry DNA ploidy correlates with histological subtypes in endometrial carcinomas , 2006, Modern Pathology.

[21]  F. Amant,et al.  Time to include high-risk early ovarian cancer in randomized phase III trials of advanced ovarian cancer. , 2006, Gynecologic oncology.

[22]  Birgitte Nielsen,et al.  Prognostic Value of Adaptive Textural Features–The Effect of Standardizing Nuclear First-Order Gray Level Statistics and Mixing Information from Nuclei Having Different Area , 2006, Cellular oncology : the official journal of the International Society for Cellular Oncology.

[23]  Fritz Albregtsen,et al.  Low dimensional adaptive texture feature vectors from class distance and class difference matrices , 2004, IEEE Transactions on Medical Imaging.

[24]  I Vergote,et al.  Large-scale genomic instability predicts long-term outcome for women with invasive stage I ovarian cancer. , 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

[25]  A. Wolffe,et al.  Chromatin remodeling: why it is important in cancer , 2001, Oncogene.

[26]  K Yogesan,et al.  Entropy-based texture analysis of chromatin structure in advanced prostate cancer. , 1996, Cytometry.

[27]  Robert M. Haralick,et al.  Textural Features for Image Classification , 1973, IEEE Trans. Syst. Man Cybern..

[28]  M. Chorváth,et al.  [Uterine Sarcomas - a review]. , 2012, Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti.

[29]  Fritz Albregtsen,et al.  Statistical nuclear texture analysis in cancer research: a review of methods and applications. , 2008, Critical reviews in oncogenesis.

[30]  Peter Devilee,et al.  Pathology and Genetics of Tumours of the Breast and Female Genital Organs , 2003 .